Browsing Tag
Sixty Degrees Pharmaceuticals Inc.
1 post
Castanospermine commercialization strategy evolves as Sixty Degrees Pharmaceuticals pursues non prescription market entry
Discover why Sixty Degrees Pharmaceuticals is shifting castanospermine toward non prescription market entry and what this means for execution, risk, and investor strategy.